Patents Assigned to Genesegues, Inc.
-
Patent number: 10987308Abstract: Disclosed are targeted sub-50 nanometer nanoparticles suitable for delivering bioactive agents of interest, and related compositions, methods, and systems, which improve the manufacturing, stability, efficacy and other aspects of therapeutic nanoparticles.Type: GrantFiled: September 3, 2015Date of Patent: April 27, 2021Assignee: GENESEGUES, INC.Inventor: Gretchen M. Unger
-
Patent number: 9650244Abstract: Disclosed are drug delivery systems and methods for extravascular administration of drug, vaccine, and/or diagnostic agents, for use in research and medical applications.Type: GrantFiled: August 25, 2011Date of Patent: May 16, 2017Assignee: Genesegues, Inc.Inventor: Gretchen Unger
-
Patent number: 9132148Abstract: The present invention relates to compositions and methods for concurrently activating antisense and double-stranded RNase (dsRNase) mechanisms for inhibiting expression of a targeted gene, by delivering a single stranded bifunctional chimeric DNA/RNA oligonucleotide optimized for siRNA activity as well as antisense activity, into the nucleus of a target cell.Type: GrantFiled: March 21, 2013Date of Patent: September 15, 2015Assignee: GeneSegues, Inc.Inventor: Gretchen M. Unger
-
Publication number: 20120225125Abstract: Disclosed are drug delivery systems and methods for extravascular administration of drug, vaccine, and/or diagnostic agents, for use in research and medical applications.Type: ApplicationFiled: August 25, 2011Publication date: September 6, 2012Applicant: GENESEGUES, INC.Inventor: Gretchen Unger
-
Publication number: 20120076735Abstract: Disclosed are drug delivery systems and methods for extravascular administration of drug, vaccine, and/or diagnostic agents, for use in research and medical applications.Type: ApplicationFiled: March 24, 2011Publication date: March 29, 2012Applicant: GENESEGUES, INC.Inventor: Gretchen Unger
-
Publication number: 20110269813Abstract: The present invention relates to compositions and methods for concurrently activating antisense and double-stranded RNase (dsRNase) mechanisms for inhibiting expression of a targeted gene, by delivering a single stranded bifunctional chimeric DNA/RNA oligonucleotide optimized for siRNA activity as well as antisense activity, into the nucleus of a target cell.Type: ApplicationFiled: February 1, 2008Publication date: November 3, 2011Applicant: GENESEGUES, INC.Inventor: Gretchen M. Unger
-
Publication number: 20100173001Abstract: Disclosed are methods for forming particles useful for the treatment of hyperproliferative disease. The method includes providing a bioactive component and a metal ion-treated biocompatible polymer component; coating the bioactive component with a surfactant having an HLB value of less than about 6.0 units under conditions which form a coated bioactive component; associating the coated bioactive component with the a metal ion-treated biocompatible polymer under conditions which associate the coated bioactive component with the metal-ion treated biocompatible polymer to form a particle, where the particles have an average diameter of less than about 50 nanometers. Related compositions and methods to treat disease using the particles are also disclosed.Type: ApplicationFiled: June 16, 2008Publication date: July 8, 2010Applicant: GENESEGUES, INC.Inventor: Gretchen M. Unger
-
Publication number: 20040137071Abstract: The present invention generally relates to nanocapsules and methods of preparing these nanocapsules. The present invention includes a method of forming a surfactant micelle and dispersing the surfactant micelle into an aqueous composition having a hydrophilic polymer to form a stabilized dispersion of surfactant micelles. The method further includes mechanically forming droplets of the stabilized dispersion of surfactant micelles, precipitating the hydrophilic polymer to form precipitated nanocapsules, incubating the nanocapsules to reduce a diameter of the nanocapsules, and filtering or centrifuging the nanocapsules.Type: ApplicationFiled: August 29, 2003Publication date: July 15, 2004Applicant: Genesegues, Inc.Inventor: Gretchen M. Unger
-
Publication number: 20040038406Abstract: Certain embodiments of the invention relate to the use of small particles in biological systems, including the delivery of biologically active agents. Some embodiments involve using a collection of particles comprising an agent, a surfactant molecule having an HLB value of less than about 6.0 units, and a polymer soluble in aqueous solution, wherein the collection of particles has an average diameter of less than about 200 nanometers, wherein the agent is a protein, carbohydrate, polypeptide, adjuvant, nucleic acid encoding a protein, visualization agent, and/or a marker.Type: ApplicationFiled: April 8, 2003Publication date: February 26, 2004Applicant: Genesegues, Inc.Inventors: Gretchen Unger, Beverly Lundell
-
Patent number: 6632671Abstract: The present invention generally relates to nanocapsules and methods of preparing these nanocapsules. The present invention includes a method of forming a surfactant micelle and dispersing the surfactant micelle into an aqueous composition having a hydrophilic polymer to form a stabilized dispersion of surfactant micelles. The method further includes mechanically forming droplets of the stabilized dispersion of surfactant micelles, precipitating the hydrophilic polymer to form precipitated nanocapsules, incubating the nanocapsules to reduce a diameter of the nanocapsules, and filtering or centrifuging the nanocapsules.Type: GrantFiled: February 28, 2001Date of Patent: October 14, 2003Assignee: Genesegues, Inc.Inventor: Gretchen M. Unger
-
Publication number: 20030170893Abstract: The present invention generally relates to nanocapsules and methods of preparing these nanocapsules. The present invention includes a method of forming a surfactant micelle and dispersing the surfactant micelle into an aqueous composition having a hydrophilic polymer to form a stabilized dispersion of surfactant micelles. The method further includes mechanically forming droplets of the stabilized dispersion of surfactant micelles, precipitating the hydrophilic polymer to form precipitated nanocapsules, incubating the nanocapsules to reduce a diameter of the nanocapsules, and filtering or centrifuging the nanocapsules.Type: ApplicationFiled: February 28, 2001Publication date: September 11, 2003Applicant: Genesegues, Inc.Inventor: Gretchen M. Unger